Drug Discovery 2018

Drug Discovery

London, United Kingdom

21^st- 22^nd March 2018 - http://www.drug-discovery.co.uk/pharmaphorum

SMi Group is proud to announce the return of Drug Discovery in 2018. The successful conference will return for its 2nd year on the 21st and 22nd March.

The pharmaceutical industry is constantly battling the same issue when trying to discover drugs; the process is timely, expensive and usually unsuccessful. Pharma companies are trying to speed up the procedure to make it more accurate and minimise drug leads which are likely to fail further on in the drug development process. Consequently, the event will focus on key developments in this very industry.

SMi’s 2^nd annual Drug Discovery conference provides an unprecedented opportunity to gain insight into the use of Artificial Intelligence in silico drug discovery, CRISPR and PROTAC’s, as well as discussing advancements in medicinal chemistry, translational medicine and 3D structure based-discovery.

With huge interest from leaders in the field, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Drug Discovery yet. This year’s event will continue to lead with its unrivalled panel of experts bringing you the most insightful presentations from our confirmed Industry-leading speakers:

Chairman - Darren Green, Director of Molecular Design,GSK

Chairman - Guido Hanauer, Chief Executive Officer, GHPC GmbH

Steve Rees, Vice President, Discovery Biology, AstraZeneca

Stevan W Djuric, PhD, Vice President, Discovery Chemistry and Technology, AbbVie

John Harling, Director of Chemistry for the Protein Degradation DPU, GSK

Ursula Egner, Director, Head of Structural Biology, Bayer AG

Ralph Minter, Director, Fellow, Antibody Discovery and Protein Engineering, MedImmune
Early bird discounts!

15^th December to save £200

31^st January to save £100

For more information please contact: +44 (0) 207 827 6020 or email: nboumediene@smi-online.co.uk